[{"id":"8d47bbb6-06cc-480c-98ad-8a291714a09d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05442580","created_at":"2022-07-05T14:54:23.025Z","updated_at":"2024-07-02T16:35:45.090Z","phase":"Phase 1","brief_title":"CART-38 in Adult AML and MM Patients","source_id_and_acronym":"NCT05442580","lead_sponsor":"University of Pennsylvania","biomarkers":" CD38 • CD34","pipe":" | ","alterations":" CD38 expression","tags":["CD38 • CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD38 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CART-38"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 05/30/2023","start_date":" 05/30/2023","primary_txt":" Primary completion: 05/01/2041","primary_completion_date":" 05/01/2041","study_txt":" Completion: 05/01/2041","study_completion_date":" 05/01/2041","last_update_posted":"2023-06-22"}]